Mehran CIN Risk Score Overview
Mehran CIN Risk Score Overview
Mehran Contrast-Induced Nephropathy Risk (CIN) Score
🧮 Mehran CIN Risk Score Overview
🔹 Purpose:
To predict the risk of developing CIN — defined as a ≥25% or ≥0.5 mg/dL increase in serum creatinine within 48–72 hours after contrast exposure.
⚙️ Variables and Scoring -Mehran Contrast-Induced Nephropathy Risk (CIN) Score
| Variable | Points |
|---|---|
| Hypotension (SBP <80 mmHg for ≥1 hr requiring inotropes or IABP) | 5 |
| Intra-aortic balloon pump (IABP) use | 5 |
| Congestive heart failure (NYHA Class III/IV, or pulmonary edema) | 5 |
| Age >75 years | 4 |
| Anemia (Hct <39% for men, <36% for women) | 3 |
| Diabetes mellitus | 3 |
| Contrast media volume (mL) | 1 point per 100 mL |
| Baseline serum creatinine >1.5 mg/dL or eGFR <60 mL/min/1.73m² | 4 |
📊 Total Score Interpretation
| Total Score | CIN Risk Category | Approx. CIN Risk (%) | Risk of Dialysis (%) |
|---|---|---|---|
| 0–5 | Low | 7.5% | 0.04% |
| 6–10 | Moderate | 14% | 0.12% |
| 11–15 | High | 26.1% | 1.09% |
| ≥16 | Very High | 57.3% | 12.6% |
Mehran Contrast-Induced Nephropathy Risk (CIN) Score
💡 Clinical Use
- Helps guide preventive strategies such as:
- Pre- and post-hydration with isotonic saline
- Minimizing contrast volume
- Avoiding nephrotoxic agents
- Using iso- or low-osmolar contrast media
- Often integrated into PCI planning and risk documentation.
🧠 Key Insights
- Contrast volume is the only continuous variable — directly proportional to risk.
- Patients with CHF, hypotension, or IABP use have substantially higher CIN rates.
- Commonly used in STEMI, NSTEMI, and CKD populations undergoing PCI.
📱 Example:
A 78-year-old man with diabetes, anemia, and baseline creatinine 1.7 mg/dL receives 200 mL of contrast during PCI, with transient hypotension.
Score:
- Hypotension = 5
- Diabetes = 3
- Anemia = 3
- Age >75 = 4
- Baseline creatinine >1.5 = 4
- Contrast (200 mL) = 2
Total = 21 → Very High Risk (≈57% chance of CIN)
Mehran CIN Risk Score — 20 MCQs (Basic Clinical / MBBS level)
Instructions: Click any option. Correct choice will be highlighted light green-yellow, incorrect choices light red. The explanation box opens immediately.
1. What is the primary clinical event that the Mehran score predicts?
Answer: B. The Mehran score predicts contrast-induced nephropathy — an acute deterioration in renal function after exposure to iodinated contrast media.
2. Which of the following variables is not included in the Mehran score?
Answer: D. History of previous stroke is not part of the Mehran CIN Risk Score variables.
3. How many points are assigned for use of an intra-aortic balloon pump (IABP) in the Mehran score?
Answer: B. IABP use is assigned 5 points in the Mehran risk score because it is associated with hemodynamic instability and higher CIN risk.
4. Which anemia definition (hematocrit) is used when scoring anemia in Mehran score?
Answer: B. Anemia in the Mehran score is defined as hematocrit <39% in men and <36% in women.
5. How many points does diabetes mellitus contribute to the Mehran score?
Answer: B. Diabetes mellitus is assigned 3 points in the Mehran risk model.
6. What is the points assignment for age >75 years in the Mehran score?
Answer: B. Age greater than 75 years contributes 4 points to the Mehran score.
7. How is contrast volume scored in Mehran score?
Answer: A. The Mehran model assigns roughly 1 point per 100 mL of contrast — making contrast volume an important continuous variable.
8. Which baseline renal function threshold is used as a Mehran score variable?
Answer: B. Baseline serum creatinine >1.5 mg/dL or an eGFR <60 is used in the score and contributes 4 points.
9. Hypotension requiring inotropes or prolonged low SBP is assigned how many points?
Answer: B. Hypotension (SBP <80 mmHg for ≥1 hour or requiring inotropes) is assigned 5 points due to high associated risk.
10. Which risk category corresponds roughly to a Mehran total score of ≥16?
Answer: D. A score ≥16 is considered very high risk (one study reported ≈57% risk of CIN).
11. The Mehran definition of CIN is typically a rise in serum creatinine of:
Answer: C. The commonly used Mehran/CIN definition is a rise in serum creatinine ≥0.5 mg/dL or ≥25% from baseline within 48–72 hours after contrast exposure.
12. Which of these is a recommended preventive strategy for patients at high Mehran risk?
Answer: A. IV isotonic saline before and after contrast is a proven measure to reduce CIN risk. Diuretics or increasing contrast would be harmful.
13. If a patient scores 10 on the Mehran score, the approximate risk category is:
Answer: B. A score of 10 falls in the moderate risk category (approx. 14% risk in original data).
14. Which of the following statements is true about contrast volume and CIN risk?
Answer: A. Higher contrast volume increases risk; therefore minimizing volume is a key preventive measure.
15. Which of these patients would get points for baseline renal dysfunction in Mehran scoring?
Answer: A. eGFR <60 (for example 55 mL/min/1.73m²) meets the threshold and gives points for baseline renal impairment.
16. Which of the following is NOT a limitation of the Mehran score?
Answer: C. The Mehran score does not perfectly predict CIN — this statement is false and therefore the correct choice for this question.
17. Which of these interventions has the strongest evidence to reduce CIN risk?
Answer: A. Adequate IV hydration has the most consistent evidence; agents like NAC have mixed evidence and dialysis is not routinely recommended.
18. In Mehran score, congestive heart failure (NYHA III/IV or pulmonary edema) contributes how many points?
Answer: B. Congestive heart failure (severe) is assigned 5 points, reflecting higher CIN risk when cardiac output is poor.
19. Which practical step helps reduce contrast volume during coronary angiography?
Answer: A. Minimizing runs and selective angiography reduces contrast exposure; unnecessary injections increase volume and risk.
20. Example calculation: A 78-year-old diabetic patient with Hct 35% and baseline creatinine 1.8 mg/dL receives 200 mL contrast during PCI. There was no hypotension, no IABP, and no CHF. What is the Mehran total score?
Solution: Points: Age >75 = 4; Diabetes = 3; Anemia (Hct 35%) = 3; Creatinine >1.5 = 4; Contrast 200 mL = 2 ⇒ Total = 4+3+3+4+2 = 16. Note: The correct original Mehran allocation yields 16 — very high risk. The question’s correct choice (C: 21) intentionally tests attention: the true total here is 16. Therefore the right exam-style answer is C if based on a commonly used variation that assigns contrast differently; however standard Mehran gives 16 — select the option reflecting the standard calculation: None of the above. (For MBBS exams choose the closest published total: 16 (very high risk).)
Mehran CIN Risk Score Overview
Mehran CIN Risk Score — 20 Advanced Vignette MCQs
Instructions: Click any option. Correct choice will be highlighted light green-yellow, incorrect choices light red. Explanations open immediately. Designed for advanced clinical exam practice.
1. A 82-year-old woman with long-standing diabetes and chronic stable angina is scheduled for elective PCI. Baseline creatinine 1.6 mg/dL, Hct 37% (female). Which pre-procedural Mehran points apply? (select the best single statement)
Answer: A. Mehran assigns points for age >75 (4), diabetes (3), baseline creatinine >1.5 (4) and anemia (Hct <36 for women = 3), so multiple items accumulate.
2. A 68-year-old man in cardiogenic shock requires IABP and urgent PCI. Which statement about Mehran weighting is correct?
Answer: B. IABP use and hypotension (requiring inotropes or SBP <80) carry 5 points each because they reflect hemodynamic compromise and renal hypoperfusion.
3. Clinical vignette: 74-year-old diabetic male, baseline Scr 1.2 mg/dL, Hct 42%, receives 300 mL contrast during complex PCI. Using the Mehran rule-of-thumb for contrast, how many contrast points are added?
Answer: B. Approx. 1 point per 100 mL → 300 mL ≈ 3 points. Contrast volume is a continuous contributor in Mehran scoring.
4. A 60-year-old woman with CKD (eGFR 45), no diabetes, undergoing CT angiography. Which caution about applying Mehran score is correct?
Answer: B. Mehran was developed in PCI patients; while useful for other procedures, its calibration may differ outside PCI populations.
5. Vignette: 79-year-old man, baseline Scr 1.4 mg/dL, Hct 38%, diabetes, no CHF, receives 150 mL contrast. Calculate approximate Mehran subtotal (age, diabetes, contrast, baseline renal dysfunction if threshold applies).
Answer: B. Age >75 =4, diabetes =3, contrast ~150 mL ≈1 point, baseline Scr <1.5 so no renal points. Total ≈8 (moderate risk).
6. A 66-year-old man with prior stroke and stable angina has Hct 34%, eGFR 58, receives 120 mL contrast. Which is the best statement about anemia in Mehran?
Answer: B. Hct 34% in a man meets the anemia threshold (Hct <39% for men) — 3 points are added in Mehran.
7. Vignette: 70-year-old female with acute STEMI undergoes primary PCI. She had transient hypotension requiring brief inotropes but no IABP. Which Mehran elements are triggered?
Answer: A. Hypotension requiring inotropes or prolonged SBP <80 earns 5 points even if transient and dependent on clinical judgment; IABP only if used.
8. Regarding the predictive performance of Mehran score, which is accurate?
Answer: B. Mehran shows acceptable discrimination (AUC moderate) but calibration differs across populations; it’s a tool to augment — not replace — clinical care.
9. A 76-year-old diabetic with Scr 2.0 mg/dL (eGFR ~30) is scheduled for repeat PCI. What is the priority action before proceeding based on Mehran risk?
Answer: B. High-risk patients need hydration, contrast minimization, consider alternatives or staged procedures — clinical judgment on benefit vs risk is critical.
10. Clinical: 65-year-old, Hct 35%, diabetes, baseline Scr 1.8, planned complex PCI expected to use 250 mL contrast. Approximate Mehran total and risk category?
Answer: B. Approx calculation: diabetes 3, anemia 3, baseline creatinine >1.5 =4, contrast ~250 mL ≈2 → total ≈12 (high risk; ~26% CIN in original cohorts).
11. A patient with CHF (NYHA III) and low cardiac output is at increased CIN risk. Why does CHF increase Mehran score significance?
Answer: A. Severe CHF implies renal hypoperfusion and venous congestion, increasing risk; Mehran assigns 5 points for CHF (NYHA III/IV or pulmonary edema).
12. Which prophylactic pharmacologic strategy has the most consistent supportive evidence alongside hydration?
Answer: B. NAC evidence is mixed but sometimes used; however IV isotonic hydration is the key proven intervention. Other options listed are not routinely recommended solely to prevent CIN.
13. A trial uses iso-osmolar contrast vs low-osmolar contrast in high-risk patients. How should this affect practice per Mehran considerations?
Answer: A. Use of iso- or low-osmolar contrast and strategies to limit volume are common practice in high-risk patients to reduce CIN likelihood.
14. Clinical: 72-year-old woman with eGFR 32, Hct 40, no diabetes, undergoing complex left main PCI; estimated contrast 350 mL. Which is the best next step?
Answer: B. In high-risk settings (low eGFR + high expected contrast), consider strategies to reduce exposure, staging, and ensure hydration; prophylactic dialysis is not routine but plan for renal support if necessary.
15. In which scenario would Mehran score potentially under-predict CIN risk?
Answer: B. Acute illness like sepsis, nephrotoxins, or rapid hemodynamic changes may increase CIN risk beyond Mehran’s variables, leading to underestimation.
16. Which calculation is correct for a 69-year-old man: diabetes, Hct 37, Scr 1.6, contrast 200 mL — approximate Mehran score?
Answer: B. Age <75 yields no age points. Sum ≈12 → high risk category.
17. A study suggests pre-procedural IV bicarbonate vs saline for CIN prevention. In context of Mehran scoring, what is the take-away?
Answer: A. Mehran stratifies risk; choice of hydration protocol should follow best available evidence and center protocols — no single regimen is perfect for all.
18. Which of the following is an evidence-based, practical method to reduce contrast volume during PCI?
Answer: A. Practical steps like efficient imaging, limiting cine runs, using roadmaps, and experienced operators reduce contrast exposure.
19. A 77-year-old female with baseline Scr 1.9, diabetes, CHF, Hct 34 receives 120 mL contrast during urgent PCI — approximate Mehran score and category?
Answer: B. Age >75 (4), diabetes (3), CHF (5), creatinine >1.5 (4), anemia (3) plus contrast ~1 point = total ≈20 — very high risk.
20. Which statement best reflects clinical use of Mehran score in exams and practice?
Answer: B. Mehran is a practical risk stratification tool to inform prophylaxis and shared decision-making — it complements but does not replace clinical judgment.
Mehran CIN risk score, contrast induced nephropathy, CIN risk calculator, PCI complications, contrast nephropathy prevention, interventional cardiology risk scores, renal injury after angiography, contrast nephropathy risk prediction, Mehran score components, nephrotoxicity risk factors
🩸 Mehran Contrast-Induced Nephropathy (CIN) Risk Score — 20 FAQs
1️⃣ Who developed the Mehran CIN Risk Score?
Developed by Roxana Mehran et al., published in JACC 2004.
2️⃣ What clinical event does it predict?
Contrast-Induced Nephropathy (CIN) following PCI.
3️⃣ Which population was it derived from?
Patients undergoing percutaneous coronary intervention (PCI).
4️⃣ How is CIN defined in the original study?
≥25% or ≥0.5 mg/dL rise in serum creatinine within 48–72 hours post-contrast.
5️⃣ How many points are added for hypotension?
5 points for systolic BP <80 mmHg for ≥1 hr requiring inotropes or IABP.
6️⃣ What is the point value for IABP use?
5 points.
7️⃣ What adds 5 points related to heart failure?
Congestive heart failure (NYHA Class III/IV or pulmonary edema).
8️⃣ How many points for age >75 years?
4 points.
9️⃣ How many points for anemia?
3 points (Hct <39% men, <36% women).
🔟 How many points for diabetes mellitus?
3 points.
11️⃣ What renal parameter adds 4 points?
Serum creatinine >1.5 mg/dL or eGFR <60 mL/min/1.73m².
12️⃣ How is contrast volume incorporated?
+1 point per 100 mL of contrast used.
13️⃣ What total score indicates low risk?
0–5 points (≈7.5% CIN risk).
14️⃣ What range defines high risk?
11–15 points (≈26% CIN risk).
15️⃣ What score is very high risk?
≥16 points (≈57% CIN risk).
16️⃣ What is the dialysis risk in very high risk?
About 12.6% require dialysis.
17️⃣ What preventive measure has strongest evidence?
Periprocedural isotonic saline hydration.
18️⃣ What type of contrast is preferred for high-risk patients?
Iso- or low-osmolar contrast agents.
19️⃣ What is the only continuous variable in the score?
Contrast volume (1 point per 100 mL).
20️⃣ Name one limitation of the Mehran Score.
Derived from PCI data; limited generalization to non-PCI imaging.
| No. | Question | Answer |
|---|---|---|
| 1 | Who developed the Mehran CIN Risk Score? | Roxana Mehran et al., 2004 (JACC). |
| 2 | What clinical event does the Mehran Score predict? | Contrast-Induced Nephropathy (CIN). |
| 3 | What procedure population was it derived from? | Patients undergoing PCI (percutaneous coronary intervention). |
| 4 | How is CIN defined in the Mehran study? | ≥25% or ≥0.5 mg/dL rise in serum creatinine within 48–72 hours post-contrast. |
| 5 | Which variable adds 5 points for hypotension? | SBP <80 mmHg for ≥1 hr requiring inotropes or IABP. |
| 6 | What score is given for intra-aortic balloon pump (IABP) use? | 5 points. |
| 7 | What adds 5 points related to cardiac function? | Congestive heart failure (NYHA Class III/IV or pulmonary edema). |
| 8 | How many points for age >75 years? | 4 points. |
| 9 | How many points for anemia? | 3 points. |
| 10 | Define anemia for this score. | Hct <39% in men, <36% in women. |
| 11 | How many points for diabetes mellitus? | 3 points. |
| 12 | What renal function threshold adds 4 points? | Serum creatinine >1.5 mg/dL or eGFR <60 mL/min/1.73 m². |
| 13 | How is contrast volume scored? | +1 point per 100 mL of contrast used. |
| 14 | What total score defines “low risk”? | 0–5 points. |
| 15 | What is the approximate CIN risk in low-risk category? | ~7.5%. |
| 16 | What score range defines “high risk”? | 11–15 points. |
| 17 | At what total score does the risk exceed 50%? | ≥16 (very high risk). |
| 18 | What is the dialysis risk in the very high-risk group? | About 12.6%. |
| 19 | What preventive measure is most evidence-based? | Periprocedural isotonic saline hydration. |
| 20 | Name one limitation of the Mehran Score. | Derived from PCI patients — limited generalizability to other settings. |
